Drug Approval | June 08, 2022
Lupin receives tentative approval from FDA for Ivacaftor tablets
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
The Innopack confex is a perfect platform for exhibitors to demonstrate their latest developments in the fields of pharmaceutical packaging, labelling, drug delivery device design and engineering.
The drug will be manufactured at the group’s topical facility at Ahmedabad
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The proposed demerger is the most significant corporate change for GSK in the last 20 years
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Subscribe To Our Newsletter & Stay Updated
